Christopher R. Seaton
Chairman at Middlesex Hospital
Profile
Christopher R.
Seaton is currently the Chairman at Middlesex Hospital and Director at Versantis AG.
He completed his undergraduate and MBA degrees from McMaster University.
Christopher R. Seaton active positions
Companies | Position | Start |
---|---|---|
Middlesex Hospital
Middlesex Hospital Hospital/Nursing ManagementHealth Services Middlesex Hospital, located in Middletown, CT, provides healthcare services to patients and families. The hospital prides itself on providing quality care and treating patients like family. | Chairman | 19/04/2010 |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Director/Board Member | 05/02/2021 |
Training of Christopher R. Seaton
McMaster University | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Middlesex Hospital
Middlesex Hospital Hospital/Nursing ManagementHealth Services Middlesex Hospital, located in Middletown, CT, provides healthcare services to patients and families. The hospital prides itself on providing quality care and treating patients like family. | Health Services |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Christopher R. Seaton